Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor (updated)

Illumina

09/04/2024 21:28

(Adds details in paragraphs 2-3)
       April 9 (Reuters) - Illumina  ILMN.O  said on Tuesday
Chief Financial Officer Joydeep Goswami would leave the gene
sequencing company and would be succeeded by former Summit
Therapeutics'  SMMT.O  executive Ankur Dhingra.
    Goswami, who has more than two decades of experience in the
life sciences industry, was the CFO since early 2023 and will
serve as an adviser till June 30, the company said.
    Illumina has also reaffirmed its forecast for the first
quarter and full-year 2024.

 (Reporting by Pritam Biswas in Bengaluru; Editing by Shilpi
Majumdar)
 ((Pritam.Biswas@thomsonreuters.com;))